← Back to results

Scientist, Lentiviral Vector Cell Line Development

Join Asimov as a Scientist to develop lentiviral vector cell lines and optimize processes in a dynamic synthetic biology startup.

Location
Boston, MA
Compensation
Not disclosed
Level
junior
Type
full time · On-site

Posted by employer 4 days ago

First seen on Joblaze 3 days ago

Last verified on the company career page 1 day ago

Apply at Asimov → Save job Scanned from asimov.com

What you'll build

  • Perform Lentiviral vector stable producer cell line development processes
  • Perform assays to assess quantity, potency and infectivity of lentiviral vector preparations
  • Support innovation through development of novel workflows and applications
  • Contribute to process development efforts, including scale-up and characterization
  • Represent LV CLD on project teams

Must have

  • PhD in Biological Engineering, Chemical Engineering, Cell Biology, Molecular Biology, or a related field
  • 0-2 years of hands-on industry experience with Lentiviral vector production
  • Extensive experience performing viral transductions
  • Strong written and verbal communication skills

Nice to have

  • Experience with Ambr15, Ambr250, and/or benchtop scale viral vector bioreactor processes
  • Experience with downstream purification of Lentiviral vectors
  • Experience with viral genome engineering
  • Experience with host cell genome engineering related to virus production

Requirements

Experience
0–2 years
Education
PhD

Not disclosed in this posting: compensation, visa sponsorship.

Joblaze summary

In this role, the Scientist focuses on developing stable producer cell lines for lentiviral vector therapeutics, engaging in processes such as transfection, cloning, and characterization. Key skills include hands-on experience with viral transductions and familiarity with bioreactor systems like Ambr15 and Ambr250. This position is suitable for candidates with a PhD or relevant master's degree and industry experience in gene therapy. Asimov fosters a collaborative environment, emphasizing diverse perspectives to advance its mission in synthetic biology.

Joblaze insights

  • Listed 3 days ago — first seen on Joblaze October 7, 2026. Last confirmed on Asimov's careers page October 9, 2026.
  • Chemical Engineering appears in 1.3% of 476 comparable junior other roles in United States; molecular biology appears in 0.2% of 476 comparable junior other roles in United States.

Quick facts

Is the Scientist, Lentiviral Vector Cell Line Development role remote?
No — this is an on-site role in Boston, MA.
How much experience is required?
0–2 years of relevant experience for this Scientist, Lentiviral Vector Cell Line Development role.
Where is the role based?
Asimov is hiring for this position in Boston, MA.
What's the tech stack?
Joblaze extracted these technologies from the posting: Ambr15, Ambr250, Biological Engineering, Chemical Engineering, Lentiviral Vector, cell biology.
What seniority level is this role?
Asimov targets junior candidates for this position.
Is this full-time or contract?
Full-time for this Scientist, Lentiviral Vector Cell Line Development role at Asimov.

From the original posting

Our mission at Asimov is to advance humanity's ability to design living systems, enabling biotechnologies with outsized benefit to society. We're developing a mammalian synthetic biology platform––from cells to software––to enable the design and manufacture of next-generation therapeutics.

We are seeking a Scientist to join our Lentiviral Vector Cell Line Development team in Boston, MA. The ideal candidate has a proven track record developing lentiviral vector (LV) packaging and stable producer cell lines in an industry setting. In this role, you will play a central part in engineering stable producer cell lines for LV therapeutics while driving upstream process optimization and scale-up. This is a unique opportunity to work at a nimble, forward-thinking synthetic biology startup and help build the future of biological engineering.


About the Role:

  • Perform Lentiviral vector stable producer cell line development processes including transfection, pool generation, cloning, characterization, and cell banking using state-of-the-art equipment.

  • Perform assays to assess quantity, potency and infectivity of lentiviral vector preparations.

  • Support innovation through development of novel workflows and applications.

  • Support research projects to develop viral vector therapeutics with enhanced quality attributes such as infectivity, potency and/or cell targeting.

  • Work effectively as part of a cross-functional team in support of the LV CLD platform and in collaboration with Synthetic Biology and Process Development teams.

  • Contribute to process development efforts, including scale-up and characterization across Ambr15, Ambr250, and benchtop systems, as well as LV analytical assay development.

  • Design experiments, analyze data, troubleshoot, and maintain detailed records.

  • Represent LV CLD on project teams, making decisions for cell line development activities and effectively communicating results, progress and plans.


About You:

  • You have a PhD in Biological Engineering, Chemical Engineering, Cell Biology, Molecular Biology, or a related field with 0-2 years of hands-on industry experience with Lentiviral vector production and cell line development in support of gene therapies; alternatively, a MS with 3-4 years or Bachelors with 6-8 years of this type of experience.

  • Extensive experience performing viral transductions, including T-cell transduction assay, flow cytometry, and quantitative gene expression analyses (ddPCR or qPCR).

  • Experience with Ambr15, Ambr250, and/or benchtop scale viral vector bioreactor processes.

  • Experience with downstream purification of Lentiviral vectors, viral genome engineering, and/or host cell genome engineering related to virus production or producer cell line technologies is highly desired.

  • Strong written and verbal communication skills required.

Standard company text repeated across Asimov's postings is omitted here.